Practical application of good participatory practices for trials of emerging pathogens: Developing materials for use in ACTIV-3, -3b, and ACTIV-associated COVID-19 trials.
Saved in:
| Title: | Practical application of good participatory practices for trials of emerging pathogens: Developing materials for use in ACTIV-3, -3b, and ACTIV-associated COVID-19 trials. |
|---|---|
| Authors: | Guerra-de-Blas PDC; The Mexican Emerging Infectious Diseases Clinical Research Network (LaRed), Mexico City, Mexico., Marines-Price R; Office of Advanced Practice Providers, University of Texas Southwestern Medical Center, Dallas, TX, USA., Milman O; The Bronx Veterans Medical Research Foundation Inc., James J. Peters Veteran Affairs Medical Center, Bronx, NY, USA., Deal D; Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Marchand J; Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Linton J; Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Meger S; Division of Biostatistics and Health Data Science, School of Public Health, University of Minnesota, Minneapolis, MN, USA., Rule J; National Association of People with HIV, Sydney, NSW, Australia., Holland TL; Division of Infectious Diseases, Duke University, Durham, NC, USA., Kitonsa J; MRC/UVRI & LSHTM Uganda Research Unit, Entebbe, Uganda., Delph Y; Axle Informatics, North Bethesda, MD, USA. |
| Corporate Authors: | INSIGHT OTAC, ACTIV-3 TICO, ACTIV-3 substudy VATICO, and ACTIV-3b TESICO Study Groups |
| Source: | Journal of clinical and translational science [J Clin Transl Sci] 2024 Oct 15; Vol. 8 (1), pp. e157. Date of Electronic Publication: 2024 Oct 15 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Cambridge University Press Country of Publication: England NLM ID: 101689953 Publication Model: eCollection Cited Medium: Internet ISSN: 2059-8661 (Electronic) Linking ISSN: 20598661 NLM ISO Abbreviation: J Clin Transl Sci Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39610837 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Practical application of good participatory practices for trials of emerging pathogens: Developing materials for use in ACTIV-3, -3b, and ACTIV-associated COVID-19 trials. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Guerra-de-Blas+PDC%22">Guerra-de-Blas PDC</searchLink>; The Mexican Emerging Infectious Diseases Clinical Research Network (LaRed), Mexico City, Mexico.<br /><searchLink fieldCode="AU" term="%22Marines-Price+R%22">Marines-Price R</searchLink>; Office of Advanced Practice Providers, University of Texas Southwestern Medical Center, Dallas, TX, USA.<br /><searchLink fieldCode="AU" term="%22Milman+O%22">Milman O</searchLink>; The Bronx Veterans Medical Research Foundation Inc., James J. Peters Veteran Affairs Medical Center, Bronx, NY, USA.<br /><searchLink fieldCode="AU" term="%22Deal+D%22">Deal D</searchLink>; Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.<br /><searchLink fieldCode="AU" term="%22Marchand+J%22">Marchand J</searchLink>; Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.<br /><searchLink fieldCode="AU" term="%22Linton+J%22">Linton J</searchLink>; Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.<br /><searchLink fieldCode="AU" term="%22Meger+S%22">Meger S</searchLink>; Division of Biostatistics and Health Data Science, School of Public Health, University of Minnesota, Minneapolis, MN, USA.<br /><searchLink fieldCode="AU" term="%22Rule+J%22">Rule J</searchLink>; National Association of People with HIV, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Holland+TL%22">Holland TL</searchLink>; Division of Infectious Diseases, Duke University, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Kitonsa+J%22">Kitonsa J</searchLink>; MRC/UVRI & LSHTM Uganda Research Unit, Entebbe, Uganda.<br /><searchLink fieldCode="AU" term="%22Delph+Y%22">Delph Y</searchLink>; Axle Informatics, North Bethesda, MD, USA. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22INSIGHT+OTAC%2C+ACTIV-3+TICO%2C+ACTIV-3+substudy+VATICO%2C+and+ACTIV-3b+TESICO+Study+Groups%22">INSIGHT OTAC, ACTIV-3 TICO, ACTIV-3 substudy VATICO, and ACTIV-3b TESICO Study Groups</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101689953%22">Journal of clinical and translational science</searchLink> [J Clin Transl Sci] 2024 Oct 15; Vol. 8 (1), pp. e157. <i>Date of Electronic Publication: </i>2024 Oct 15 (<i>Print Publication: </i>2024). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Cambridge+University+Press%22">Cambridge University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101689953 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2059-8661 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220598661%22">20598661 </searchLink><i>NLM ISO Abbreviation: </i>J Clin Transl Sci <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39610837 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1017/cts.2024.485 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e157 Titles: – TitleFull: Practical application of good participatory practices for trials of emerging pathogens: Developing materials for use in ACTIV-3, -3b, and ACTIV-associated COVID-19 trials. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Guerra-de-Blas PDC – PersonEntity: Name: NameFull: Marines-Price R – PersonEntity: Name: NameFull: Milman O – PersonEntity: Name: NameFull: Deal D – PersonEntity: Name: NameFull: Marchand J – PersonEntity: Name: NameFull: Linton J – PersonEntity: Name: NameFull: Meger S – PersonEntity: Name: NameFull: Rule J – PersonEntity: Name: NameFull: Holland TL – PersonEntity: Name: NameFull: Kitonsa J – PersonEntity: Name: NameFull: Delph Y IsPartOfRelationships: – BibEntity: Dates: – D: 15 M: 10 Text: 2024 Oct 15 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 2059-8661 Numbering: – Type: volume Value: 8 – Type: issue Value: 1 Titles: – TitleFull: Journal of clinical and translational science Type: main |
| ResultId | 1 |